IRCT20231015059724N1 IRCT 2023-10-24 Oroumia University of Medical Sciences Investigating the effect of boswellic acid in acute ischemic stroke patients Investigating the effect of boswellic acid on the clinical outcomes of patients with acute ischemic stroke 2023-11-22 anticipated 70 Complete https://irct.ir/trial/73224 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients will be randomly assigned to one of the intervention or control groups using computer-generated numbers produced by the Random allocation software. Thus, in this software, the number of groups and the total sample size will be entered, and then the "randomization" will be implemented in the block section. Then, the computer-generated number list will be given to the physician, and the physician will assign patients to groups according to the determined order by the software for entry into one of the groups. Thus, the randomization process will continue until the final sample size is reached. 3 Acute ischemic stroke. Intervention 1: Intervention group: Patients in the intervention group, in addition to routine stroke treatments that include anti-ischemic drugs, will receive oral boswellic acid 360 mg tablets from Gol Daru every 6 hours for one month. Intervention 2: Control group: In the control group, routine stroke treatments including anti-ischemic drugs will be performed. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is Confidentiality of patient information